Rate My Professor Blake Gibson

Blake Gibson has co-authored several peer-reviewed publications and conference contributions, demonstrating his involvement in cutting-edge research. Key works include: Fairhall, J. M., Camilli, J. C., Gibson, B. H., Hook, S., & Gamble, A. B. (2021). EGFR-targeted prodrug activation using bioorthogonal alkene-azide click-and-release chemistry. Bioorganic & Medicinal Chemistry, 46, 116361. Goh, P. W. L., Gibson, B., & Rizwan, S. B. (2021). Oleoylethanolamide cubosomes exert potent anti-inflammatory effects on lipopolysaccharide-induced dendritic cells and human brain endothelial cells. New Zealand Medical Journal, 134 (1535), 97-98. von Halling Laier, C., Gibson, B., Moreno, J. A. S., Rades, T., Hook, S., Nielsen, L. H., & Boisen, A. (2019). Microcontainers for protection of oral vaccines, in vitro and in vivo evaluation. Journal of Controlled Release, 294, 91-101. Matikonda, S. S., Fairhall, J. M., Dadhwal, S., Gibson, B., Garden, A., Hook, S., & Gamble, A. B. (2018). Bioorthogonal prodrug activation, verbal presentation at Queenstown Molecular Biology Meetings. Naciute, M., Niemi, G., Gibson, B., Kemp, R., & Hook, S. (2018). Immune response to oral therapeutic vaccination against colorectal cancer, verbal presentation at Queenstown Molecular Biology and Australasian Society for Immunology New Zealand Branch Joint Meeting. These contributions highlight his support for research in prodrug activation, vaccine protection, anti-inflammatory formulations, and immunotherapy.